Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christelle Ries Fecourt"'
Autor:
Christel Aebischer-Gumy, Pierre Moretti, Romain Ollier, Christelle Ries Fecourt, François Rousseau, Martin Bertschinger
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
We describe a mammalian expression construct (SPLICELECT™) that allows the redirection of a proportion of a secreted protein onto the cell surface using alternative splicing: whereas the majority of the RNA is spliced into a transcript encoding a s
Externí odkaz:
https://doaj.org/article/e0f179f587654572a76204c3e4419814
Autor:
Romain Ollier, François Rousseau, Christel Aebischer-Gumy, Martin Bertschinger, Christelle Ries Fecourt, Pierre Moretti
Publikováno v:
mAbs
We describe a mammalian expression construct (SPLICELECT™) that allows the redirection of a proportion of a secreted protein onto the cell surface using alternative splicing: whereas the majority of the RNA is spliced into a transcript encoding a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75335e733ca90c4764ff3ca17e5cc246
http://europepmc.org/articles/PMC6973322
http://europepmc.org/articles/PMC6973322
Autor:
M.Lamine Mbow, Marie-Agnès Doucey, Julie Macoin, Blandine Pouleau, Riccardo Turrini, Cian Stutz, Stanislas Blein, Amelie Croset, Carole Estoppey, Adam Drake, Mario Perro, Amélie Laurendon, Emilie Nallet, Christelle Ries-Fecourt, Perrine Suere, Thierry Monney, Mégane Pluess
Publikováno v:
Journal of Clinical Oncology. 39:8044-8044
8044 Background: ISB 1342 is a bispecific antibody heterodimer based on the Ichnos proprietary Bispecific Engagement by Antibodies based on T cell receptor (BEAT) platform. ISB 1342 is a first-in-class CD38 T cell engager under investigation in subje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47706610737de16efa6998a7f3090b87
https://doi.org/10.1200/jco.2021.39.15_suppl.8044
https://doi.org/10.1200/jco.2021.39.15_suppl.8044